Xiaofei Lü

999 total citations
28 papers, 796 citations indexed

About

Xiaofei Lü is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Xiaofei Lü has authored 28 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Xiaofei Lü's work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Xiaofei Lü is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). Xiaofei Lü collaborates with scholars based in China, United States and Pakistan. Xiaofei Lü's co-authors include Yuxin Chen, Yunfei Xu, Xiaoqin Luo, Wenhua Ling, Zhiwen Yu, Min Xia, Naveed Ahmad, Farooq Anwar, Yuegang Zuo and Sohail Hameed and has published in prestigious journals such as PLoS ONE, Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaofei Lü

27 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Lü China 15 275 168 163 136 114 28 796
Guangju Guan China 23 543 2.0× 130 0.8× 222 1.4× 83 0.6× 129 1.1× 43 1.4k
Jiagen Wen China 19 515 1.9× 97 0.6× 97 0.6× 145 1.1× 121 1.1× 47 1.1k
Xiaohui Bian China 15 316 1.1× 154 0.9× 103 0.6× 65 0.5× 69 0.6× 38 837
Srinivas D Sithu United States 19 368 1.3× 125 0.7× 140 0.9× 182 1.3× 111 1.0× 24 1.2k
Pnina Scherzer Israel 7 333 1.2× 185 1.1× 262 1.6× 78 0.6× 219 1.9× 10 1.0k
José Luis Morgado‐Pascual Spain 14 478 1.7× 80 0.5× 80 0.5× 84 0.6× 77 0.7× 23 1.0k
Zhiquan Chen China 20 495 1.8× 143 0.9× 49 0.3× 130 1.0× 82 0.7× 37 910
Xuguang Hu China 15 379 1.4× 107 0.6× 156 1.0× 163 1.2× 78 0.7× 48 814
Sungmi Park South Korea 17 397 1.4× 58 0.3× 83 0.5× 118 0.9× 79 0.7× 38 1.0k
Jing Zong China 22 503 1.8× 145 0.9× 200 1.2× 154 1.1× 82 0.7× 51 1.2k

Countries citing papers authored by Xiaofei Lü

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Lü more than expected).

Fields of papers citing papers by Xiaofei Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Lü. The network helps show where Xiaofei Lü may publish in the future.

Co-authorship network of co-authors of Xiaofei Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Lü. A scholar is included among the top collaborators of Xiaofei Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Lü. Xiaofei Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zijie, Xiaofei Lü, Na Weng, et al.. (2025). Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer. Advanced Science. 12(19). e2501623–e2501623. 3 indexed citations
2.
Chen, Zhiyang, Zhenhui Li, Xiaofei Lü, et al.. (2024). AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection. JHEP Reports. 7(2). 101270–101270. 5 indexed citations
3.
Li, Qian, et al.. (2024). Association of inflammatory cytokines with magnetic resonance imaging features of the brain in patients with depression. Brain Research Bulletin. 219. 111131–111131. 1 indexed citations
4.
Li, Jia, et al.. (2023). Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram. BMC Medical Imaging. 23(1). 153–153. 3 indexed citations
6.
He, Haiping, Ping Wang, Shan Zeng, et al.. (2022). The therapeutic effect of an autologous and allogenic mixed glioma cell lysate vaccine in a rat model. Journal of Cancer Research and Clinical Oncology. 149(2). 609–622. 2 indexed citations
7.
Yuan, Juanjuan, Xiaojun Zheng, Xiaofei Lü, et al.. (2021). Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein & Cell. 12(4). 240–260. 101 indexed citations
8.
Liu, Xiaoyan, Zhiwei Huang, Shenyan Zhang, et al.. (2021). Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4+ T Cells in the Central Region of pMMR CRC. Frontiers in Oncology. 11. 724232–724232. 9 indexed citations
9.
Liu, Xiaoyun, et al.. (2020). Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer. Irish Journal of Medical Science (1971 -). 190(1). 59–65. 17 indexed citations
10.
Chen, Yuxin, et al.. (2016). Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction. OncoTargets and Therapy. Volume 9. 4343–4349. 21 indexed citations
11.
Zhao, Song, et al.. (2016). Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer. PLoS ONE. 11(1). e0146233–e0146233. 21 indexed citations
12.
Ahmad, Naveed, Yuegang Zuo, Xiaofei Lü, Farooq Anwar, & Sohail Hameed. (2015). Characterization of free and conjugated phenolic compounds in fruits of selected wild plants. Food Chemistry. 190. 80–89. 79 indexed citations
13.
Lü, Xiaofei, et al.. (2015). The expression and clinical significance of HDGF in osteosarcoma. OncoTargets and Therapy. 8. 2509–2509. 10 indexed citations
14.
Xu, Yunfei, Xiaoqing Yang, Xiaofei Lü, et al.. (2014). Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Biochemical and Biophysical Research Communications. 446(1). 54–60. 80 indexed citations
15.
Nie, Hui, Yunyi Hong, Xiaofei Lü, et al.. (2014). SIRT2 mediates oxidative stress-induced apoptosis of differentiated PC12 cells. Neuroreport. 25(11). 838–842. 46 indexed citations
16.
Yu, Zhiwen, et al.. (2012). Vitamin D attenuates high fat diet–induced hepatic steatosis in rats by modulating lipid metabolism. European Journal of Clinical Investigation. 42(11). 1189–1196. 108 indexed citations
17.
Ning, Shanglei, Sen Guo, Jian‐Jun Xie, et al.. (2012). TROP2 Correlates with Microvessel Density and Poor Prognosis in Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 17(2). 360–368. 33 indexed citations
18.
Shi, Baomin, et al.. (2009). Selective periesophagogastric devascularization in portal hypertension: results of 56 patients.. PubMed. 56(90). 492–7. 9 indexed citations
19.
Cheng, Baoquan, et al.. (2008). Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Digestive and Liver Disease. 40(6). 446–452. 86 indexed citations
20.
Xu, Hao, Baomin Shi, Xiaofei Lü, et al.. (2008). Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats. World Journal of Gastroenterology. 14(15). 2349–2349. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026